| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | endopeptidase activity | 9.40e-04 | 430 | 53 | 6 | GO:0004175 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 1.94e-03 | 93 | 53 | 3 | GO:0097110 | |
| GeneOntologyMolecularFunction | protein-cysteine S-palmitoyltransferase activity | 2.16e-03 | 26 | 53 | 2 | GO:0019706 | |
| GeneOntologyMolecularFunction | protein-cysteine S-acyltransferase activity | 2.16e-03 | 26 | 53 | 2 | GO:0019707 | |
| GeneOntologyMolecularFunction | zinc ion binding | 2.27e-03 | 891 | 53 | 8 | GO:0008270 | |
| GeneOntologyMolecularFunction | Notch binding | 2.33e-03 | 27 | 53 | 2 | GO:0005112 | |
| GeneOntologyMolecularFunction | S-acyltransferase activity | 2.87e-03 | 30 | 53 | 2 | GO:0016417 | |
| GeneOntologyBiologicalProcess | myelination | 1.28e-05 | 206 | 52 | 6 | GO:0042552 | |
| GeneOntologyBiologicalProcess | axon ensheathment | 1.39e-05 | 209 | 52 | 6 | GO:0008366 | |
| GeneOntologyBiologicalProcess | ensheathment of neurons | 1.39e-05 | 209 | 52 | 6 | GO:0007272 | |
| GeneOntologyBiologicalProcess | regulation of viral transcription | 3.34e-05 | 25 | 52 | 3 | GO:0046782 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane neurotransmitter receptor levels | 5.75e-05 | 164 | 52 | 5 | GO:0099072 | |
| GeneOntologyCellularComponent | glutamatergic synapse | SEMA3F USP6 NETO1 MTOR PRSS12 CNTNAP2 RNF216 CHD4 ITGB4 ADAM22 NOTCH1 | 4.23e-06 | 817 | 52 | 11 | GO:0098978 |
| GeneOntologyCellularComponent | cerebellar granule cell to Purkinje cell synapse | 1.26e-04 | 7 | 52 | 2 | GO:0150048 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 5.97e-04 | 155 | 52 | 4 | GO:0098685 | |
| GeneOntologyCellularComponent | extracellular matrix | 1.14e-03 | 656 | 52 | 7 | GO:0031012 | |
| GeneOntologyCellularComponent | asymmetric synapse | 1.15e-03 | 477 | 52 | 6 | GO:0032279 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.16e-03 | 658 | 52 | 7 | GO:0030312 | |
| GeneOntologyCellularComponent | asymmetric, glutamatergic, excitatory synapse | 1.62e-03 | 24 | 52 | 2 | GO:0098985 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.83e-03 | 523 | 52 | 6 | GO:0098984 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.96e-03 | 530 | 52 | 6 | GO:0062023 | |
| GeneOntologyCellularComponent | axon initial segment | 2.36e-03 | 29 | 52 | 2 | GO:0043194 | |
| GeneOntologyCellularComponent | excitatory synapse | 2.40e-03 | 107 | 52 | 3 | GO:0060076 | |
| Domain | EGF_1 | ATRN FAT4 ATRNL1 CNTNAP2 SCUBE3 PLAU LRP1B ITGB4 ADAM22 NOTCH1 | 1.20e-09 | 255 | 50 | 10 | PS00022 |
| Domain | EGF-like_CS | ATRN FAT4 ATRNL1 CNTNAP2 SCUBE3 PLAU LRP1B ITGB4 ADAM22 NOTCH1 | 1.50e-09 | 261 | 50 | 10 | IPR013032 |
| Domain | EGF_2 | ATRN FAT4 ATRNL1 CNTNAP2 SCUBE3 PLAU LRP1B ITGB4 ADAM22 NOTCH1 | 1.74e-09 | 265 | 50 | 10 | PS01186 |
| Domain | EGF_3 | 1.08e-08 | 235 | 50 | 9 | PS50026 | |
| Domain | EGF | 1.08e-08 | 235 | 50 | 9 | SM00181 | |
| Domain | EGF_extracell | 1.21e-08 | 60 | 50 | 6 | IPR013111 | |
| Domain | EGF_2 | 1.21e-08 | 60 | 50 | 6 | PF07974 | |
| Domain | EGF-like_dom | 1.79e-08 | 249 | 50 | 9 | IPR000742 | |
| Domain | PSI | 5.70e-06 | 44 | 50 | 4 | IPR016201 | |
| Domain | PSI | 6.83e-06 | 46 | 50 | 4 | SM00423 | |
| Domain | CUB | 8.81e-06 | 49 | 50 | 4 | PF00431 | |
| Domain | CUB | 9.56e-06 | 50 | 50 | 4 | SM00042 | |
| Domain | - | 1.12e-05 | 52 | 50 | 4 | 2.60.120.290 | |
| Domain | CUB | 1.21e-05 | 53 | 50 | 4 | PS01180 | |
| Domain | CUB_dom | 1.62e-05 | 57 | 50 | 4 | IPR000859 | |
| Domain | - | 2.10e-05 | 3 | 50 | 2 | 4.10.1130.10 | |
| Domain | EGF | 2.14e-05 | 126 | 50 | 5 | PF00008 | |
| Domain | SRCR | 2.32e-05 | 21 | 50 | 3 | PF00530 | |
| Domain | SR | 3.98e-05 | 25 | 50 | 3 | SM00202 | |
| Domain | - | 3.98e-05 | 25 | 50 | 3 | 3.10.250.10 | |
| Domain | SRCR_1 | 4.49e-05 | 26 | 50 | 3 | PS00420 | |
| Domain | SRCR_2 | 4.49e-05 | 26 | 50 | 3 | PS50287 | |
| Domain | SRCR-like_dom | 4.49e-05 | 26 | 50 | 3 | IPR017448 | |
| Domain | SRCR | 5.05e-05 | 27 | 50 | 3 | IPR001190 | |
| Domain | Growth_fac_rcpt_ | 5.96e-05 | 156 | 50 | 5 | IPR009030 | |
| Domain | EGF_CA | 8.21e-05 | 86 | 50 | 4 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 1.31e-04 | 97 | 50 | 4 | IPR018097 | |
| Domain | EGF_CA | 1.42e-04 | 99 | 50 | 4 | PS01187 | |
| Domain | ASX_HYDROXYL | 1.47e-04 | 100 | 50 | 4 | PS00010 | |
| Domain | Peptidase_M12B_N | 1.54e-04 | 39 | 50 | 3 | IPR002870 | |
| Domain | Pep_M12B_propep | 1.54e-04 | 39 | 50 | 3 | PF01562 | |
| Domain | DISINTEGRIN_1 | 1.66e-04 | 40 | 50 | 3 | PS00427 | |
| Domain | Reprolysin | 1.66e-04 | 40 | 50 | 3 | PF01421 | |
| Domain | ADAM_MEPRO | 1.66e-04 | 40 | 50 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 1.66e-04 | 40 | 50 | 3 | PS50214 | |
| Domain | Peptidase_M12B | 1.66e-04 | 40 | 50 | 3 | IPR001590 | |
| Domain | Disintegrin_dom | 1.79e-04 | 41 | 50 | 3 | IPR001762 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.85e-04 | 106 | 50 | 4 | IPR000152 | |
| Domain | BTK | 2.50e-04 | 9 | 50 | 2 | SM00107 | |
| Domain | Znf_Btk_motif | 2.50e-04 | 9 | 50 | 2 | IPR001562 | |
| Domain | BTK | 2.50e-04 | 9 | 50 | 2 | PF00779 | |
| Domain | ZF_BTK | 2.50e-04 | 9 | 50 | 2 | PS51113 | |
| Domain | EGF_CA | 3.16e-04 | 122 | 50 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 3.37e-04 | 124 | 50 | 4 | IPR001881 | |
| Domain | RasGAP | 6.26e-04 | 14 | 50 | 2 | SM00323 | |
| Domain | RasGAP_CS | 6.26e-04 | 14 | 50 | 2 | IPR023152 | |
| Domain | TSP_1 | 6.40e-04 | 63 | 50 | 3 | PF00090 | |
| Domain | TSP1 | 7.02e-04 | 65 | 50 | 3 | SM00209 | |
| Domain | TSP1_rpt | 7.02e-04 | 65 | 50 | 3 | IPR000884 | |
| Domain | TSP1 | 7.02e-04 | 65 | 50 | 3 | PS50092 | |
| Domain | RasGAP | 7.21e-04 | 15 | 50 | 2 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_1 | 7.21e-04 | 15 | 50 | 2 | PS00509 | |
| Domain | RAS_GTPASE_ACTIV_2 | 7.21e-04 | 15 | 50 | 2 | PS50018 | |
| Domain | - | 8.23e-04 | 16 | 50 | 2 | 1.10.506.10 | |
| Domain | Kringle | 9.31e-04 | 17 | 50 | 2 | IPR000001 | |
| Domain | Kringle_CS | 9.31e-04 | 17 | 50 | 2 | IPR018056 | |
| Domain | KRINGLE_2 | 9.31e-04 | 17 | 50 | 2 | PS50070 | |
| Domain | Kringle | 9.31e-04 | 17 | 50 | 2 | PF00051 | |
| Domain | KRINGLE_1 | 9.31e-04 | 17 | 50 | 2 | PS00021 | |
| Domain | KR | 9.31e-04 | 17 | 50 | 2 | SM00130 | |
| Domain | RasGAP_dom | 1.05e-03 | 18 | 50 | 2 | IPR001936 | |
| Domain | MetalloPept_cat_dom | 1.33e-03 | 81 | 50 | 3 | IPR024079 | |
| Domain | - | 1.33e-03 | 81 | 50 | 3 | 3.40.390.10 | |
| Domain | ADAM_spacer1 | 1.71e-03 | 23 | 50 | 2 | IPR010294 | |
| Domain | ADAM_spacer1 | 1.71e-03 | 23 | 50 | 2 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 1.87e-03 | 24 | 50 | 2 | IPR013273 | |
| Domain | DHHC | 2.03e-03 | 25 | 50 | 2 | PS50216 | |
| Domain | Znf_DHHC_palmitoyltrfase | 2.03e-03 | 25 | 50 | 2 | IPR001594 | |
| Domain | cEGF | 2.19e-03 | 26 | 50 | 2 | IPR026823 | |
| Domain | cEGF | 2.19e-03 | 26 | 50 | 2 | PF12662 | |
| Domain | - | 2.27e-03 | 207 | 50 | 4 | 1.25.40.10 | |
| Domain | ZINC_PROTEASE | 2.30e-03 | 98 | 50 | 3 | PS00142 | |
| Domain | ACR | 2.36e-03 | 27 | 50 | 2 | SM00608 | |
| Domain | ADAM_Cys-rich | 2.36e-03 | 27 | 50 | 2 | IPR006586 | |
| Domain | hEGF | 2.54e-03 | 28 | 50 | 2 | PF12661 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 3.23e-05 | 68 | 38 | 4 | M27303 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.54e-04 | 39 | 38 | 3 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.54e-04 | 39 | 38 | 3 | MM15165 | |
| Pubmed | 2.95e-07 | 9 | 54 | 3 | 23095891 | ||
| Pubmed | WDR19 ATRN PSAP ADAMTS1 ADAMTS9 NETO1 ATRNL1 TRIM8 RNF216 CHD4 LRP1B ADAM22 | 5.01e-07 | 1285 | 54 | 12 | 35914814 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 28331227 | ||
| Pubmed | Akt-mTOR signaling is involved in Notch-1-mediated glioma cell survival and proliferation. | 2.37e-06 | 2 | 54 | 2 | 20372862 | |
| Pubmed | Macrophage-released ADAMTS1 promotes muscle stem cell activation. | 2.37e-06 | 2 | 54 | 2 | 28939843 | |
| Pubmed | CAPRI regulates Ca(2+)-dependent inactivation of the Ras-MAPK pathway. | 2.37e-06 | 2 | 54 | 2 | 11448776 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 27473087 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 30446843 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 21631271 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 18064672 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 16041389 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 35384384 | ||
| Pubmed | Mutual regulation between TRIM21 and TRIM8 via K48-linked ubiquitination. | 2.37e-06 | 2 | 54 | 2 | 37914816 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 31874168 | ||
| Pubmed | NOTCH knockdown affects the proliferation and mTOR signaling of leukemia cells. | 7.09e-06 | 3 | 54 | 2 | 24122995 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 19147749 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 22004682 | ||
| Pubmed | Differential gene expression of ADAMTS-1, ADAMTS-9 and TIMP-3 in periodontitis. | 7.09e-06 | 3 | 54 | 2 | 36093887 | |
| Pubmed | CD28 inhibits T cell adhesion by recruiting CAPRI to the plasma membrane. | 7.09e-06 | 3 | 54 | 2 | 25637021 | |
| Pubmed | ZDHHC19 localizes to the cell membrane of spermatids and is involved in spermatogenesisâ . | 7.09e-06 | 3 | 54 | 2 | 34897408 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 22907434 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 25213258 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 31758376 | ||
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 23562508 | ||
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 31270884 | ||
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 21460216 | ||
| Pubmed | Notch-modifying xylosyltransferase structures support an SNi-like retaining mechanism. | 1.42e-05 | 4 | 54 | 2 | 26414444 | |
| Pubmed | ZDHHC11 modulates innate immune response to DNA virus by mediating MITA-IRF3 association. | 1.42e-05 | 4 | 54 | 2 | 29429998 | |
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 16234249 | ||
| Pubmed | 2.36e-05 | 5 | 54 | 2 | 20089912 | ||
| Pubmed | Notch inhibits apoptosis by direct interference with XIAP ubiquitination and degradation. | 2.36e-05 | 5 | 54 | 2 | 17318174 | |
| Pubmed | Genetic and phenotypic studies of the dark-like mutant mouse. | 2.36e-05 | 5 | 54 | 2 | 18821597 | |
| Pubmed | 2.36e-05 | 5 | 54 | 2 | 22562232 | ||
| Pubmed | Control of cardiac jelly dynamics by NOTCH1 and NRG1 defines the building plan for trabeculation. | 2.87e-05 | 38 | 54 | 3 | 29743679 | |
| Pubmed | 3.38e-05 | 117 | 54 | 4 | 17145500 | ||
| Pubmed | 3.54e-05 | 6 | 54 | 2 | 11384978 | ||
| Pubmed | Proteolytic cleavage of versican during cardiac cushion morphogenesis. | 3.54e-05 | 6 | 54 | 2 | 16691565 | |
| Pubmed | ZDHHC11 Positively Regulates NF-ÎșB Activation by Enhancing TRAF6 Oligomerization. | 3.54e-05 | 6 | 54 | 2 | 34490261 | |
| Pubmed | 4.94e-05 | 7 | 54 | 2 | 15599946 | ||
| Pubmed | 4.94e-05 | 7 | 54 | 2 | 23687301 | ||
| Pubmed | 4.94e-05 | 7 | 54 | 2 | 23354118 | ||
| Pubmed | Comparative genome mapping in the sequence-based era: early experience with human chromosome 7. | 6.59e-05 | 8 | 54 | 2 | 10810084 | |
| Pubmed | FBW7 Mediates Senescence and Pulmonary Fibrosis through Telomere Uncapping. | 6.59e-05 | 8 | 54 | 2 | 33086033 | |
| Pubmed | 6.59e-05 | 8 | 54 | 2 | 12105188 | ||
| Pubmed | BANK1 and BLK act through phospholipase C gamma 2 in B-cell signaling. | 8.46e-05 | 9 | 54 | 2 | 23555801 | |
| Pubmed | TRIM27 negatively regulates NOD2 by ubiquitination and proteasomal degradation. | 8.46e-05 | 9 | 54 | 2 | 22829933 | |
| Pubmed | Expression of signaling components in embryonic eyelid epithelium. | 1.06e-04 | 10 | 54 | 2 | 24498290 | |
| Pubmed | PIBF1 regulates trophoblast syncytialization and promotes cardiovascular development. | 1.08e-04 | 59 | 54 | 3 | 38374152 | |
| Pubmed | Zinc transporter Slc39a8 is essential for cardiac ventricular compaction. | 1.29e-04 | 11 | 54 | 2 | 29337306 | |
| Pubmed | Missense Mutation in Human CHD4 Causes Ventricular Noncompaction by Repressing ADAMTS1. | 1.29e-04 | 11 | 54 | 2 | 37254794 | |
| Pubmed | 1.29e-04 | 11 | 54 | 2 | 33909046 | ||
| Pubmed | 1.29e-04 | 11 | 54 | 2 | 24348274 | ||
| Pubmed | 1.38e-04 | 64 | 54 | 3 | 22261194 | ||
| Pubmed | CHD4-regulated plasmin activation impacts lymphovenous hemostasis and hepatic vascular integrity. | 1.55e-04 | 12 | 54 | 2 | 27140400 | |
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 1.55e-04 | 12 | 54 | 2 | 25770910 | |
| Pubmed | Decidual PTEN expression is required for trophoblast invasion in the mouse. | 1.83e-04 | 13 | 54 | 2 | 20858757 | |
| Pubmed | 1.83e-04 | 13 | 54 | 2 | 32909945 | ||
| Pubmed | 2.13e-04 | 14 | 54 | 2 | 21349854 | ||
| Pubmed | 2.13e-04 | 14 | 54 | 2 | 20585571 | ||
| Pubmed | 2.21e-04 | 75 | 54 | 3 | 20637190 | ||
| Pubmed | FBXO45-MYCBP2 regulates mitotic cell fate by targeting FBXW7 for degradation. | 2.45e-04 | 15 | 54 | 2 | 31285543 | |
| Pubmed | Sall4 regulates cell fate decision in fetal hepatic stem/progenitor cells. | 2.80e-04 | 16 | 54 | 2 | 19185577 | |
| Pubmed | 2.80e-04 | 16 | 54 | 2 | 30579834 | ||
| Pubmed | 2.80e-04 | 16 | 54 | 2 | 17021047 | ||
| Pubmed | 3.17e-04 | 17 | 54 | 2 | 22183742 | ||
| Pubmed | 3.56e-04 | 18 | 54 | 2 | 23077300 | ||
| Pubmed | TRIM-mediated precision autophagy targets cytoplasmic regulators of innate immunity. | 3.98e-04 | 19 | 54 | 2 | 26347139 | |
| Pubmed | 4.42e-04 | 20 | 54 | 2 | 19922873 | ||
| Pubmed | 4.62e-04 | 415 | 54 | 5 | 16385451 | ||
| Pubmed | Canonical notch signaling functions as a commitment switch in the epidermal lineage. | 4.88e-04 | 21 | 54 | 2 | 17079689 | |
| Pubmed | 4.88e-04 | 21 | 54 | 2 | 30662561 | ||
| Pubmed | 4.88e-04 | 21 | 54 | 2 | 25707359 | ||
| Pubmed | TRIM E3 ligases interfere with early and late stages of the retroviral life cycle. | 4.88e-04 | 21 | 54 | 2 | 18248090 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 5.01e-04 | 1201 | 54 | 8 | 35696571 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 5.29e-04 | 101 | 54 | 3 | 23382219 | |
| Pubmed | 5.86e-04 | 23 | 54 | 2 | 29567669 | ||
| Pubmed | Genome-wide Identification of Foxf2 Target Genes in Palate Development. | 5.86e-04 | 23 | 54 | 2 | 32040930 | |
| Pubmed | Cis-Repression of Foxq1 Expression Affects Foxf2-Mediated Gene Expression in Palate Development. | 5.86e-04 | 23 | 54 | 2 | 33898467 | |
| Pubmed | 5.86e-04 | 23 | 54 | 2 | 24337118 | ||
| Pubmed | 5.93e-04 | 105 | 54 | 3 | 9628581 | ||
| Pubmed | 6.08e-04 | 441 | 54 | 5 | 12853948 | ||
| Pubmed | 6.39e-04 | 24 | 54 | 2 | 29791855 | ||
| Pubmed | 6.39e-04 | 24 | 54 | 2 | 32043969 | ||
| Pubmed | 6.39e-04 | 24 | 54 | 2 | 19680556 | ||
| Pubmed | Stromal Fat4 acts non-autonomously with Dchs1/2 to restrict the nephron progenitor pool. | 6.39e-04 | 24 | 54 | 2 | 26116661 | |
| Pubmed | 6.89e-04 | 257 | 54 | 4 | 16335952 | ||
| Pubmed | Common variants at ten loci influence QT interval duration in the QTGEN Study. | 6.94e-04 | 25 | 54 | 2 | 19305408 | |
| Pubmed | 7.51e-04 | 26 | 54 | 2 | 25446530 | ||
| Pubmed | Mass spectrometry-based proteomics revealed Glypican-1 as a novel ADAM17 substrate. | 7.92e-04 | 116 | 54 | 3 | 27576135 | |
| Pubmed | 8.10e-04 | 27 | 54 | 2 | 20490451 | ||
| Pubmed | mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation. | 8.10e-04 | 27 | 54 | 2 | 27807348 | |
| Pubmed | 9.35e-04 | 29 | 54 | 2 | 26620267 | ||
| Pubmed | 1.07e-03 | 31 | 54 | 2 | 22274697 | ||
| Pubmed | Semaphorin 3E/PlexinD1 signaling is required for cardiac ventricular compaction. | 1.14e-03 | 32 | 54 | 2 | 31434798 | |
| Pubmed | 1.21e-03 | 33 | 54 | 2 | 18199763 | ||
| Pubmed | Galnt1 is required for normal heart valve development and cardiac function. | 1.44e-03 | 36 | 54 | 2 | 25615642 | |
| Pubmed | Cardiac-specific developmental and epigenetic functions of Jarid2 during embryonic development. | 1.44e-03 | 36 | 54 | 2 | 29891551 | |
| Interaction | DYRK1A interactions | ATRN PSAP ADAMTS1 ADAMTS9 ATRNL1 RNF216 TRIM21 LRP1B ITGB4 ADAM22 | 1.77e-06 | 552 | 54 | 10 | int:DYRK1A |
| Cytoband | 4q28.1 | 1.61e-04 | 16 | 54 | 2 | 4q28.1 | |
| Cytoband | 5p15.33 | 6.58e-04 | 32 | 54 | 2 | 5p15.33 | |
| GeneFamily | Pleckstrin homology domain containing|SH2 domain containing|C2 and RasGAP domain containing | 2.34e-04 | 10 | 42 | 2 | 830 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 8.79e-04 | 19 | 42 | 2 | 50 | |
| GeneFamily | Zinc fingers DHHC-type|Ankyrin repeat domain containing | 1.41e-03 | 24 | 42 | 2 | 76 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 4.08e-03 | 41 | 42 | 2 | 1298 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_UP | 3.10e-06 | 196 | 54 | 6 | M5256 | |
| Coexpression | NABA_ECM_REGULATORS | 9.44e-06 | 238 | 54 | 6 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 1.04e-05 | 242 | 54 | 6 | MM17062 | |
| Coexpression | NABA_MATRISOME | SEMA3F ANOS1 ADAMTS1 ADAMTS9 PRSS12 SPON1 SCUBE3 PLAU LOXL3 ADAM22 | 4.04e-05 | 1026 | 54 | 10 | M5889 |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Intestinal_macrophages|Liver / Manually curated celltypes from each tissue | 1.30e-06 | 156 | 54 | 5 | 9a897fc79c4fae94c5f2e9012d65297f9225e5e3 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.98e-06 | 170 | 54 | 5 | 1a568efcff9c39b3f709b55a05d24710450a2657 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.98e-06 | 170 | 54 | 5 | 66d41d794790e621d72ac37af995510537103c9c | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.41e-06 | 190 | 54 | 5 | 141266bf411ea675fbf889b20c1b08673c45ff95 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Endothelial-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.06e-06 | 197 | 54 | 5 | f969685dee212f33a6f09e54c0cd1fd24ffef546 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.06e-06 | 197 | 54 | 5 | 96d63a8d00583e2aa0a38412e2ae27e23f399493 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Endothelial-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.06e-06 | 197 | 54 | 5 | 1a137af40697137bb9d2b5caf2b1ffda55f04461 | |
| ToppCell | PCW_10-12|World / Celltypes from embryonic and fetal-stage human lung | 4.06e-06 | 197 | 54 | 5 | 47fd8b0d596c5db1a722473c8efbb17a6bbe7538 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.27e-06 | 199 | 54 | 5 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / Treatment groups by lineage, cell group, cell type | 4.37e-06 | 200 | 54 | 5 | b036f5e22c95a3b14391785b6e91aa183b9bc9a8 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Vein|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.37e-06 | 200 | 54 | 5 | b3f93b71589251197cde96b7bc6d065c106f61cd | |
| ToppCell | Control_saline-Endothelial-Endothelial-Vein|Control_saline / Treatment groups by lineage, cell group, cell type | 4.37e-06 | 200 | 54 | 5 | e5f876910bc8cb390d9b46a48d9b6d4d57235551 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.04e-05 | 158 | 54 | 4 | d78e7e52657dc094430291fec07e9c298be9e584 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-05 | 162 | 54 | 4 | 68c40d12689cc1b6c797e6e48173f0110f8144e4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.45e-05 | 162 | 54 | 4 | 735fa3f77b31a4189e431d05c326403c18cbbffb | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.56e-05 | 163 | 54 | 4 | 1e8730d75cccf7292010683ab4e81a69d8e3bfa9 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.67e-05 | 164 | 54 | 4 | d2218d50e0e2d19f919dcb460b3840687c082810 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_4|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.37e-05 | 170 | 54 | 4 | 439167e44a1bd5ac8e1e457351dd202ec968db46 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-like|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.49e-05 | 171 | 54 | 4 | 3ad4f138d9570500cfb4423a2be16bb7d1cacbf8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.49e-05 | 171 | 54 | 4 | 972fab891135bd755d5526cbc5a963200067b0a6 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-like-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.49e-05 | 171 | 54 | 4 | ca2775a17b5c339c480a963953b6fa2b0731f24d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.49e-05 | 171 | 54 | 4 | 2a77ed79c6f2e700e789c80451a70ecb31639719 | |
| ToppCell | 5'-Adult-LargeIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.49e-05 | 171 | 54 | 4 | dd37e1693a5cfc42e40992d504f92048a8038b52 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel|Adult / Lineage, Cell type, age group and donor | 5.62e-05 | 172 | 54 | 4 | ad4ffdb3fc0c560a9cbaa2bc048476cbc43e8fd6 | |
| ToppCell | Basal_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 5.88e-05 | 174 | 54 | 4 | a0060be3940043015dcc49a5157de5541aed24a1 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.28e-05 | 177 | 54 | 4 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.42e-05 | 178 | 54 | 4 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-mo-Mac|normal_Pleural_Fluid / Location, Cell class and cell subclass | 6.56e-05 | 179 | 54 | 4 | cd3c58e044f5a38e815313a1636153d81a592fce | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.56e-05 | 179 | 54 | 4 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-05 | 180 | 54 | 4 | af2bafcd1b2082629de3ea336711add01565c4c4 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.70e-05 | 180 | 54 | 4 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-4|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 6.70e-05 | 180 | 54 | 4 | 886ebaf9cf8992e8dd13fca799a1d1a2a9ce73d8 | |
| ToppCell | facs-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-05 | 180 | 54 | 4 | 12537d8a569faa69f474284d2c201475722b8ca1 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.70e-05 | 180 | 54 | 4 | f29a995cf6e1a1836ed68b73258d9370bf3d4434 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.00e-05 | 182 | 54 | 4 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.15e-05 | 183 | 54 | 4 | a644258ba90acc62d571623e429d72ffc4b69203 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.15e-05 | 183 | 54 | 4 | bc98df870de65aff6dab295c24cbc199c7f2aa15 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Degenerative_Connecting_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.30e-05 | 184 | 54 | 4 | 9690d4290e70f9bda889754ffb30b0af1f7cb94b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.45e-05 | 185 | 54 | 4 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.45e-05 | 185 | 54 | 4 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.45e-05 | 185 | 54 | 4 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | Endothelial-A-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 7.45e-05 | 185 | 54 | 4 | dee0b7ba2f338f0979d2306aedf52ac35a36b60c | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.45e-05 | 185 | 54 | 4 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | Endothelial-A-Donor_01|World / lung cells shred on cell class, cell subclass, sample id | 7.61e-05 | 186 | 54 | 4 | 796cbae2a417502aaf0891fc9c382bbfd88967fe | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 7.77e-05 | 187 | 54 | 4 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | 367C-Endothelial_cells-Endothelial-D|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.77e-05 | 187 | 54 | 4 | 1342bc614bc4045263c2eb0a535a1dd6c64e7abe | |
| ToppCell | 367C-Endothelial_cells-Endothelial-D-|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.77e-05 | 187 | 54 | 4 | 7aa206262b14b9f2aaa99e59da38b96c3594d2c9 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-05 | 187 | 54 | 4 | 9aa411ae9b5a923378a5daebb8bb2fc2613f2510 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-05 | 189 | 54 | 4 | 476226787c8ea0c9834a6f4c99ac7091cc20a455 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 8.10e-05 | 189 | 54 | 4 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.10e-05 | 189 | 54 | 4 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-05 | 189 | 54 | 4 | 3fe69bad6427e41b8d2dae450828cc21e9c3b3ad | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.10e-05 | 189 | 54 | 4 | 55a1776a4ce049959b3f13a43744c7314bc1f00a | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.10e-05 | 189 | 54 | 4 | d9c2adbbe3e40eb8d57200b6411533e6685ea0d2 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.10e-05 | 189 | 54 | 4 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.10e-05 | 189 | 54 | 4 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | ASK428-Epithelial-Transformed_epithelium|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.10e-05 | 189 | 54 | 4 | 87189275234b5d59484c58acbb14a09903f2b578 | |
| ToppCell | IPF-Epithelial-Basal|Epithelial / Disease state, Lineage and Cell class | 8.26e-05 | 190 | 54 | 4 | 4f15842b424eefadbfe451875e517cf70e29607f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 8.26e-05 | 190 | 54 | 4 | 938d1f66094b1c94606e0d40213a39e5112f3322 | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.26e-05 | 190 | 54 | 4 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.26e-05 | 190 | 54 | 4 | f6c38d197fd9d69a4f97cb2e72cd4747984c1a86 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.26e-05 | 190 | 54 | 4 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.26e-05 | 190 | 54 | 4 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | Endothelial-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 8.43e-05 | 191 | 54 | 4 | f702dfe88a9b04091dae87df61b2b4f43525f86a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.43e-05 | 191 | 54 | 4 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.43e-05 | 191 | 54 | 4 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.60e-05 | 192 | 54 | 4 | 945153c41dde6e90d103206955e1707b54eb0665 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Endothelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.60e-05 | 192 | 54 | 4 | 6ab50579c63f31ca2cd41063a99b129f11c07510 | |
| ToppCell | facs-Pancreas-Exocrine-3m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.78e-05 | 193 | 54 | 4 | c3161a14a40323a58aa202c8a1d6ea0e9c2b9814 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.78e-05 | 193 | 54 | 4 | 5b602b1702283184bd3943c2a6f2290b7c37e407 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.78e-05 | 193 | 54 | 4 | c8c21eee8c6c086dc2faf416669cd4a002870fbe | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Endothelial-endothelial_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.13e-05 | 195 | 54 | 4 | 4db30b3bc65c25626f828cd4f867f20c71809898 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.13e-05 | 195 | 54 | 4 | 023e3c97dd3696d74f002ff8da0c04d876c82aef | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.32e-05 | 196 | 54 | 4 | c5fe470f11ee4962bcfb30cddfd8c078af5b1222 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.32e-05 | 196 | 54 | 4 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.32e-05 | 196 | 54 | 4 | 3a6c942e2907aa07b5e12dbf9019d18f7bfca507 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.32e-05 | 196 | 54 | 4 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.32e-05 | 196 | 54 | 4 | 5609b2d93172a488b35d854298a3a4e504e17e28 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.32e-05 | 196 | 54 | 4 | bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70 | |
| ToppCell | ASK454-Endothelial-Endothelium|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.32e-05 | 196 | 54 | 4 | 2b777a2026b56839112fd179f2db482c49f4594a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.50e-05 | 197 | 54 | 4 | 09946ee8dfb15a2a32da06e5b331f3277ee934f4 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.50e-05 | 197 | 54 | 4 | ad4a3b5da2190be9495382a2952991e1de9f190d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.50e-05 | 197 | 54 | 4 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.50e-05 | 197 | 54 | 4 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.50e-05 | 197 | 54 | 4 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.69e-05 | 198 | 54 | 4 | 79576525a10ed3e3a9d1608077cd16ecda23376f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.69e-05 | 198 | 54 | 4 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.69e-05 | 198 | 54 | 4 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.69e-05 | 198 | 54 | 4 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | distal-3-Endothelial-Bronchial_Vessel_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.69e-05 | 198 | 54 | 4 | 00fdee373eaa43c9ce897f2ba2ecbe94cedea93a | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 9.88e-05 | 199 | 54 | 4 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.88e-05 | 199 | 54 | 4 | a207b4891881149d4c50721310690fd794157723 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.88e-05 | 199 | 54 | 4 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Vein|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.88e-05 | 199 | 54 | 4 | cfb624c7728046fc7f3ef071f57e4d7b013f3fef | |
| ToppCell | ILEUM-inflamed-(7)_ACKR1+_endothelial_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.88e-05 | 199 | 54 | 4 | 5c799115a6e95bcd896e4ad10bd272705c9a4e2c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.88e-05 | 199 | 54 | 4 | 3cd6383c50ce342fe5c175e2e50784d634a90e80 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-04 | 200 | 54 | 4 | 78d75d381cb2b9a4c9eb7c32a07b014eaee39195 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.01e-04 | 200 | 54 | 4 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-04 | 200 | 54 | 4 | 84e145619a500530f42ed0fe72468ae95f4cbf1e | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 1.01e-04 | 200 | 54 | 4 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| Drug | Lobelanidine hydrochloride [6112-86-3]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 5.85e-06 | 198 | 52 | 6 | 5500_UP | |
| Drug | Fenoterol hydrobromide [1944-12-3]; Up 200; 10.4uM; PC3; HT_HG-U133A | 5.92e-05 | 182 | 52 | 5 | 6331_UP | |
| Drug | acarbose | 6.34e-05 | 94 | 52 | 4 | CID000041774 | |
| Drug | Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 6.73e-05 | 187 | 52 | 5 | 5204_UP | |
| Drug | Triflupromazine hydrochloride [1098-60-8]; Up 200; 10.2uM; PC3; HT_HG-U133A | 7.44e-05 | 191 | 52 | 5 | 1813_UP | |
| Drug | Doxorubicin hydrochloride [25316-40-9]; Up 200; 6.8uM; MCF7; HT_HG-U133A | 7.44e-05 | 191 | 52 | 5 | 3291_UP | |
| Drug | Cimetidine [51481-61-9]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 7.82e-05 | 193 | 52 | 5 | 1464_DN | |
| Drug | Equilin [474-86-2]; Down 200; 15uM; MCF7; HT_HG-U133A | 8.01e-05 | 194 | 52 | 5 | 5255_DN | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 8.01e-05 | 194 | 52 | 5 | 6778_DN | |
| Drug | Halcinonide [3093-35-4]; Down 200; 8.8uM; HL60; HT_HG-U133A | 8.01e-05 | 194 | 52 | 5 | 2185_DN | |
| Drug | Naproxen [22204-53-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A | 8.01e-05 | 194 | 52 | 5 | 5457_DN | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 8.21e-05 | 195 | 52 | 5 | 2223_DN | |
| Drug | Antazoline hydrochloride [2508-72-7]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 8.21e-05 | 195 | 52 | 5 | 3173_DN | |
| Drug | Chlorambucil [305-03-3]; Up 200; 13.2uM; PC3; HT_HG-U133A | 8.41e-05 | 196 | 52 | 5 | 4523_UP | |
| Drug | Solanine alpha [20562-02-1]; Down 200; 4.6uM; MCF7; HT_HG-U133A | 8.41e-05 | 196 | 52 | 5 | 4166_DN | |
| Drug | CP-944629 [668990-94-1]; Up 200; 10uM; PC3; HT_HG-U133A | 8.41e-05 | 196 | 52 | 5 | 7502_UP | |
| Drug | Dubinidine [22964-77-8]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 8.61e-05 | 197 | 52 | 5 | 6250_UP | |
| Drug | Sulfamethoxazole [723-46-6]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 8.61e-05 | 197 | 52 | 5 | 4690_UP | |
| Drug | Bromopride [4093-35-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 8.82e-05 | 198 | 52 | 5 | 6037_UP | |
| Drug | Probenecid [57-66-9]; Down 200; 14uM; PC3; HT_HG-U133A | 8.82e-05 | 198 | 52 | 5 | 4185_DN | |
| Drug | Thonzonium bromide [553-08-2]; Down 200; 6.8uM; MCF7; HT_HG-U133A | 8.82e-05 | 198 | 52 | 5 | 5678_DN | |
| Drug | Epirizole [18694-40-1]; Up 200; 17uM; MCF7; HT_HG-U133A | 9.03e-05 | 199 | 52 | 5 | 5995_UP | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; PC3; HT_HG-U133A | 9.03e-05 | 199 | 52 | 5 | 4016_DN | |
| Drug | Brinzolamide [138890-62-7]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 9.03e-05 | 199 | 52 | 5 | 3230_UP | |
| Drug | Meclocycline sulfosalicylate [73816-42-9]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 9.03e-05 | 199 | 52 | 5 | 4982_UP | |
| Disease | Nephronophthisis, familial juvenile | 6.12e-05 | 7 | 51 | 2 | C1855681 | |
| Disease | congenital heart disease | 1.48e-04 | 59 | 51 | 3 | EFO_0005207 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 1.59e-04 | 157 | 51 | 4 | DOID:224 (biomarker_via_orthology) | |
| Disease | Internal Carotid Artery Diseases | 1.59e-04 | 11 | 51 | 2 | C0750986 | |
| Disease | Arterial Diseases, Common Carotid | 1.59e-04 | 11 | 51 | 2 | C0750987 | |
| Disease | Carotid Atherosclerosis | 1.59e-04 | 11 | 51 | 2 | C0577631 | |
| Disease | External Carotid Artery Diseases | 1.59e-04 | 11 | 51 | 2 | C0600178 | |
| Disease | Carotid Artery Diseases | 1.59e-04 | 11 | 51 | 2 | C0007273 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 3.03e-04 | 15 | 51 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 3.03e-04 | 15 | 51 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 3.03e-04 | 15 | 51 | 2 | C0154091 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 3.46e-04 | 16 | 51 | 2 | C0334634 | |
| Disease | information processing speed | 4.35e-04 | 85 | 51 | 3 | EFO_0004363 | |
| Disease | Carcinoma of bladder | 4.40e-04 | 18 | 51 | 2 | C0699885 | |
| Disease | disease free survival | 4.40e-04 | 18 | 51 | 2 | EFO_0000409 | |
| Disease | obesity (implicated_via_orthology) | 5.24e-04 | 215 | 51 | 4 | DOID:9970 (implicated_via_orthology) | |
| Disease | status epilepticus (implicated_via_orthology) | 6.02e-04 | 21 | 51 | 2 | DOID:1824 (implicated_via_orthology) | |
| Disease | sciatic neuropathy (implicated_via_orthology) | 7.24e-04 | 23 | 51 | 2 | DOID:11446 (implicated_via_orthology) | |
| Disease | peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease | 7.89e-04 | 24 | 51 | 2 | EFO_0003948, EFO_0009923, MONDO_0004247 | |
| Disease | Early Pregnancy Loss | 8.98e-04 | 109 | 51 | 3 | C3830362 | |
| Disease | Miscarriage | 8.98e-04 | 109 | 51 | 3 | C4552766 | |
| Disease | Spontaneous abortion | 8.98e-04 | 109 | 51 | 3 | C0000786 | |
| Disease | Abortion, Tubal | 8.98e-04 | 109 | 51 | 3 | C0000822 | |
| Disease | Glioblastoma Multiforme | 9.46e-04 | 111 | 51 | 3 | C1621958 | |
| Disease | Carcinoma, Granular Cell | 1.07e-03 | 116 | 51 | 3 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 1.07e-03 | 116 | 51 | 3 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 1.07e-03 | 116 | 51 | 3 | C0205642 | |
| Disease | Carcinoma, Cribriform | 1.07e-03 | 116 | 51 | 3 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 1.07e-03 | 116 | 51 | 3 | C0205641 | |
| Disease | Adenocarcinoma | 1.07e-03 | 116 | 51 | 3 | C0001418 | |
| Disease | intellectual disability (is_implicated_in) | 1.24e-03 | 30 | 51 | 2 | DOID:1059 (is_implicated_in) | |
| Disease | Squamous cell carcinoma of lung | 1.41e-03 | 32 | 51 | 2 | C0149782 | |
| Disease | IGA Glomerulonephritis | 1.59e-03 | 34 | 51 | 2 | C0017661 | |
| Disease | cervical cancer | 1.59e-03 | 34 | 51 | 2 | C4048328 | |
| Disease | Uterine Cervical Neoplasm | 1.68e-03 | 35 | 51 | 2 | C0007873 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WSWQQCHCKEGLTGK | 4181 | Q6V0I7 | |
| GNCGKDKDTWIQCNK | 581 | Q9P0K1 | |
| KWSCCHQKEKTGQGC | 691 | O43374 | |
| QKSVQCGTWTKHAEG | 36 | Q8TDF5 | |
| KWSCCHQKEKTGQGC | 691 | C9J798 | |
| EGKWCINGKCVNKTD | 536 | Q9UHI8 | |
| NGSLVWCQNHKQCSK | 71 | P23352 | |
| IEQCPKSSWGEHNCG | 356 | P56730 | |
| CDKGWSAHNSHVVCG | 201 | P58215 | |
| SPCKNGGKCWQTHTQ | 1066 | P46531 | |
| LCCTGQWEDAQKLQH | 256 | Q86XE5 | |
| SNGQCIPAKWKCDGH | 3561 | Q9NZR2 | |
| GEVQQKCHQFCGWEG | 251 | O60942 | |
| NWKGEACDIPHCTDN | 276 | O75882 | |
| EGANVCRHGKLCWLQ | 106 | Q8NHP7 | |
| TDCHVLRKKAWQDCG | 91 | Q9UGM5 | |
| SFEPQKCWKNNVGHC | 21 | Q8N687 | |
| QKWCTVTKCAGGHDD | 721 | P49916 | |
| SCVQCQAWGTGEKKG | 631 | P16144 | |
| KNLSWGLNCKNIGHE | 441 | Q8IYK2 | |
| PAACKHLWKCGVENQ | 291 | A2A2Y4 | |
| LWCNNVNGVHKGCRT | 541 | Q9P2N4 | |
| VTCGKGHKHRQVWCQ | 1066 | Q9P2N4 | |
| KVQCFHCGGGLANWK | 36 | Q96P09 | |
| KCENTKVFHGWLQCD | 1051 | Q9UFH2 | |
| KCWFAEGKICHGGID | 451 | P51841 | |
| FCTVHWQEGGRCKQS | 421 | Q96RY5 | |
| NAGPGIKCVWNKNHC | 626 | Q5VV63 | |
| NHCEHGGKCSQTWDS | 561 | Q9UHC6 | |
| LICNGNESALWNCKH | 226 | Q86VB7 | |
| EGKWSCPHCEKEGIQ | 406 | Q14839 | |
| HWNGKDCTEPLKCQG | 391 | Q8IX30 | |
| ALGEWGQLHQQCCEK | 1486 | P42345 | |
| EAHGCCWKTEAQNLK | 156 | Q3SY00 | |
| QWSECNKSCGKGHVI | 676 | Q9HCB6 | |
| SNIHWCNCPKKFGGQ | 46 | P00749 | |
| LNDDGGHCCLVNKWS | 301 | Q13275 | |
| VQKLVKVCNGHDCWS | 131 | Q8NEK8 | |
| ETCRKCQGLWKEHNG | 631 | Q9NWF9 | |
| CQGLWKEHNGLTCEE | 636 | Q9NWF9 | |
| GKHTKRITCGCWNAE | 136 | Q8NEZ3 | |
| SQGNIHCSDKGSWCE | 91 | Q9UNK4 | |
| HSGCVNCLEWNEKGD | 46 | Q8N5D0 | |
| AAQEKDKGVCQGWHC | 46 | Q6ZV60 | |
| CWQKRAQGSHSKCEE | 241 | Q6ICB4 | |
| KHIVDWCGCSPNDFK | 566 | Q86Y38 | |
| DCGAVKHCLQTVWNK | 41 | P07602 | |
| DGKALCWVCAQSRKH | 106 | P19474 | |
| KCVSGFDHHCKWINN | 146 | Q9H8X9 | |
| MCGKNCNSEKQWQGH | 861 | Q8IWR0 | |
| LCNSCTSKDGRKWNH | 396 | Q9H5U6 | |
| QGFSGQLCCWLTKEH | 96 | Q8N446 | |
| SGNDHGNWCIIAEKK | 436 | Q9P272 | |
| DCNCKDIHGWKSQVV | 151 | Q16600 | |
| KCVSGFDHHCKWINN | 146 | P0C7U3 | |
| KHNFCRGCIGEAWAK | 31 | Q9BZR9 | |
| WHQDKEGLCGQCASL | 251 | P35125 |